BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20844086)

  • 1. Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model.
    Golden JW; Hooper JW
    Clin Vaccine Immunol; 2010 Nov; 17(11):1656-65. PubMed ID: 20844086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
    Golden JW; Zaitseva M; Kapnick S; Fisher RW; Mikolajczyk MG; Ballantyne J; Golding H; Hooper JW
    Virol J; 2011 Sep; 8():441. PubMed ID: 21933385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.
    Golden JW; Hooper JW
    Virology; 2008 Jul; 377(1):19-29. PubMed ID: 18482742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW
    J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW; Golden JW; Ferro AM; King AD
    Vaccine; 2007 Feb; 25(10):1814-23. PubMed ID: 17240007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.
    Golden JW; Josleyn M; Mucker EM; Hung CF; Loudon PT; Wu TC; Hooper JW
    PLoS One; 2012; 7(7):e42353. PubMed ID: 22860117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
    Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing the natural diversity of the human antibody response against vaccinia virus.
    Lantto J; Haahr Hansen M; Rasmussen SK; Steinaa L; Poulsen TR; Duggan J; Dennis M; Naylor I; Easterbrook L; Bregenholt S; Haurum J; Jensen A
    J Virol; 2011 Feb; 85(4):1820-33. PubMed ID: 21147924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
    J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
    Otero M; Calarota SA; Dai A; De Groot AS; Boyer JD; Weiner DB
    Vaccine; 2006 May; 24(21):4461-70. PubMed ID: 16137803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
    Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
    Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW; Custer DM; Thompson E
    Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
    Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
    J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
    Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
    Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.
    Ramírez M; Santos S; Martínez O; Rodríguez R; Miranda E; Ramos-Perez WD; Otero M
    Vaccine; 2018 Apr; 36(15):2049-2055. PubMed ID: 29525282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.